Creegan & Nassoura Financial Group, LLC Abbott Laboratories Transaction History

Creegan & Nassoura Financial Group, LLC

$147 Million
Q1 2025

A detailed history of Creegan & Nassoura Financial Group, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Creegan & Nassoura Financial Group, LLC holds 12,945 shares of ABT stock, worth $1.71 Million. This represents 1.17% of its overall portfolio holdings.

Number of Shares

12,945

Previous 13,120 1.33%

Holding current value

$1.71 Million

Previous $1.48 Million 15.7%

% of portfolio

1.17%

Previous 1.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$111.1 - $140.22 $19,442 - $24,538	-175 Reduced 1.33%	12,945 $1.72 Million
Q4 2024 Feb 14, 2025	SELL	$111.93 - $119.39 $19,587 - $20,893	-175 Reduced 1.32%	13,120 $1.48 Million
Q3 2024 Nov 14, 2024	SELL	$100.07 - $118.13 $17,512 - $20,672	-175 Reduced 1.3%	13,295 $1.52 Million
Q2 2024 Aug 14, 2024	SELL	$100.73 - $112.44 $25,182 - $28,110	-250 Reduced 1.82%	13,470 $1.4 Million
Q1 2024 May 15, 2024	SELL	$109.52 - $120.96 $2,190 - $2,419	-20 Reduced 0.15%	13,720 $1.56 Million
Q3 2023 Nov 14, 2023	SELL	$95.53 - $114.62 $11,941 - $14,327	-125 Reduced 0.9%	13,740 $1.33 Million
Q2 2023 Aug 14, 2023	SELL	$100.78 - $112.29 $8,767 - $9,769	-87 Reduced 0.62%	13,865 $1.51 Million
Q2 2022 Aug 15, 2022	BUY	$102.07 - $123.37 $102 - $123	1 Added 0.01%	13,952 $1.52 Million
Q1 2022 May 16, 2022	SELL	$114.02 - $139.04 $1,596 - $1,946	-14 Reduced 0.1%	13,951 $1.65 Million
Q4 2021 Feb 14, 2022	SELL	$115.53 - $141.46 $49,100 - $60,120	-425 Reduced 2.95%	13,965 $1.97 Million
Q3 2021 Nov 15, 2021	SELL	$116.66 - $129.06 $31,964 - $35,362	-274 Reduced 1.87%	14,390 $1.7 Million
Q2 2021 Aug 16, 2021	SELL	$105.79 - $124.53 $39,565 - $46,574	-374 Reduced 2.49%	14,664 $1.7 Million
Q1 2021 May 17, 2021	SELL	$108.84 - $128.23 $50,392 - $59,370	-463 Reduced 2.99%	15,038 $1.8 Million
Q4 2020 Feb 16, 2021	BUY	$105.0 - $114.42 $105 - $114	1 Added 0.01%	15,501 $1.7 Million
Q2 2020 Aug 14, 2020	SELL	$76.57 - $98.0 $22,511 - $28,812	-294 Reduced 1.86%	15,500 $1.42 Million
Q1 2020 May 15, 2020	SELL	$62.82 - $91.86 $4,648 - $6,797	-74 Reduced 0.47%	15,794 $1.25 Million
Q4 2019 Feb 14, 2020	BUY	$78.51 - $87.4 $1.25 Million - $1.39 Million	15,868 New	15,868 $1.38 Million

Others Institutions Holding ABT

# of Institutions

3,541

Shares Held

1.38B

Call Options Held

9.75M

Put Options Held

8.87M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $231B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Creegan & Nassoura Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Creegan & Nassoura Financial Group, LLC with notifications on news.

Account

Creegan & Nassoura Financial Group, LLC Abbott Laboratories Transaction History